These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7221948)

  • 21. Changes in drug resistance of bacteria in China.
    Li JT
    Int J Clin Pract Suppl; 2000 Dec; (115):27-9. PubMed ID: 11219297
    [No Abstract]   [Full Text] [Related]  

  • 22. The challenge of multidrug resistance: the treatment of gram-negative rod infections.
    Levin AS; Oliveira MS
    Shock; 2008 Oct; 30 Suppl 1():30-3. PubMed ID: 18704012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial agents in neonatal septicaemia in Calabar, Nigeria (a review of 100 cases).
    Antia-Obong OE; Utsalo SJ
    West Afr J Med; 1993; 12(2):114-7. PubMed ID: 8398930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of antibiotics for empiric treatment of serious infections.
    Gupta BL; Singh S; Rattan A; Bhujwala RA
    J Assoc Physicians India; 1994 Feb; 42(2):124-5. PubMed ID: 7860472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic osteomyelitis, its pathogens. Analysis of 79 cases (1978/1979) (author's transl)].
    Augsburg J
    Zentralbl Chir; 1981; 106(7):449-54. PubMed ID: 7245948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent trends in and dangers of gram negative bacillus infections].
    Mashimo K
    Nihon Rinsho; 1977; 35(3):1354-9. PubMed ID: 325246
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibacterial drug resistance of gram-negative agents causing urinary infections in female outpatients in Russia: results of multicenter study].
    Strachunskiĭ LS; Sekhin SV; Abramova ER; Reshed'ko GK; Petrochenkova NA; Eĭdel'shteĭn IA; Suvorov MM; Krechikova OI; Il'ina VN; Petrova TA; Gugutsidze EN; Furletova NM
    Ter Arkh; 2000; 72(6):30-5. PubMed ID: 10900645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U
    Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of microorganisms recovered from intraabdominal infections at Belo Horizonte, Brazil.
    dos Santos SG; de Carvalho MA; Serufo JC; Pinto-Silva RA; Albuquerque W; Rosa RV; Pires Ade F; Hahn RC; Hamdan JS; Nicoli JR; Farias Lde M
    Am J Infect Control; 2004 Nov; 32(7):414-6. PubMed ID: 15525917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical study of netilmicin therapy of hospitalized patients with gram-negative infections.
    Meyers BR; Hirschman SZ; Strougo LG; Wormser GP
    Mt Sinai J Med; 1981; 48(1):42-6. PubMed ID: 7010122
    [No Abstract]   [Full Text] [Related]  

  • 32. Gentamycin--its range and efficacy.
    J Assoc Physicians India; 1978 Oct; 26(10):933-4. PubMed ID: 750574
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gentamycin].
    Blumenberg D
    Krankenpfl J; 1988; 26(1-2):28, 34. PubMed ID: 3352213
    [No Abstract]   [Full Text] [Related]  

  • 34. The gram-positive bacilli: a review of the microbiology, clinical aspects, and antimicrobial susceptibilities of a heterogeneous group of bacteria.
    Berkowitz FE
    Pediatr Infect Dis J; 1994 Dec; 13(12):1126-38. PubMed ID: 7892083
    [No Abstract]   [Full Text] [Related]  

  • 35. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long term care units--nest of resistant bacteria?].
    Laine J; Lumio J
    Duodecim; 2005; 121(15):1679-81. PubMed ID: 16211842
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of gentamicin in intratracheal administration].
    Klastersky J; Noterman J; Daneau D; Hensgens C
    Acta Clin Belg; 1972; 27(5):600-9. PubMed ID: 4669782
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of gentamycin in renal failure (our experience in 31 patients)].
    Rentero R; Vidaur F; Naranjo P; Fereres J
    Rev Clin Esp; 1974 Mar; 132(5):451-4. PubMed ID: 4831276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.